Divi's Laboratories · NSE: DIVISLAB · BSE: 532488
Q1 FY27 results · Apr–Jun 2026
Divi's Laboratories reported revenue from operations of ₹3,080.00 crore (up 27.8% from Q1 FY26) and net profit of ₹902.00 crore (up 65.5% from Q1 FY26) for Q1 FY27 (Apr–Jun 2026), on a consolidated basis.
| Item | Q1 FY27 | Q1 FY26 | YoY | Q4 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 3,080.00 | 2,410.00 | +27.8% | 2,831.00 | +8.8% |
| Other income | 64.00 | 119.00 | −46.2% | 155.00 | −58.7% |
| Total income | 3,144.00 | 2,529.00 | +24.3% | 2,986.00 | +5.3% |
| Profit before tax | 1,180.00 | 733.00 | +61.0% | 963.00 | +22.5% |
| Net profit for the period | 902.00 | 545.00 | +65.5% | 751.00 | +20.1% |
| EPS, basic (₹) | 33.95 | 20.49 | +65.7% | 28.31 | +19.9% |
| Net margin (%) | 29.3 | 22.6 | 26.5 |
| Item | Q1 FY27 | Q1 FY26 | YoY | Q4 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 2,974.00 | 2,357.00 | +26.2% | 2,793.00 | +6.5% |
| Other income | 63.00 | 119.00 | −47.1% | 154.00 | −59.1% |
| Total income | 3,037.00 | 2,476.00 | +22.7% | 2,947.00 | +3.1% |
| Profit before tax | 1,165.00 | 747.00 | +56.0% | 971.00 | +20.0% |
| Net profit for the period | 891.00 | 557.00 | +60.0% | 756.00 | +17.9% |
| EPS, basic (₹) | 33.55 | 20.95 | +60.1% | 28.44 | +18.0% |
| Net margin (%) | 30.0 | 23.6 | 27.1 |
Consolidated
- Filed with BSE
- 01 Aug 2026, 12:57 IST
- Board meeting
- 01 Aug 2026
- Period
- 01 Apr 2026 to 30 Jun 2026
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 01 Aug 2026, 12:57 IST
- Board meeting
- 01 Aug 2026
- Period
- 01 Apr 2026 to 30 Jun 2026
- Review status
- Unaudited
- Source
- XBRL filing on BSE